Balance Sheet

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1943.1061.4 (+3.26 %)
PREV CLOSE ( ) 1881.70
OPEN PRICE ( ) 1888.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18731
TODAY'S LOW / HIGH ( )1888.45 1963.15
52 WK LOW / HIGH ( )1228 2649.95
NSE1946.6066.8 (+3.55 %)
PREV CLOSE( ) 1879.80
OPEN PRICE ( ) 1890.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1946.60 (91)
VOLUME 120032
TODAY'S LOW / HIGH( ) 1890.45 1962.35
52 WK LOW / HIGH ( )1227 2524
Select year
( in Million)
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
EQUITY AND LIABILITIES
Share Capital1694.061694.061694.061694.061694.06
    Equity - Authorised1800.001800.001800.001800.001800.00
    Equity - Issued1694.151694.151694.151694.151694.15
    Equity Paid Up1694.061694.061694.061694.061694.06
    Equity Shares Forfeited0.000.000.000.000.00
    Adjustments to Equity0.000.000.000.000.00
    Preference Capital Paid Up0.000.000.000.000.00
    Face Value10.0010.0010.0010.0010.00
Share Warrants & Outstandings-16.770.000.000.000.00
Total Reserves15735.4424935.5013088.5416511.9919704.23
    Securities Premium0.000.000.000.000.00
    Capital Reserves-190.70-190.70-191.1017.1017.10
    Profit & Loss Account Balance8285.7417425.435560.418755.1811907.70
    General Reserves7785.037785.037785.037785.037785.03
    Other Reserves-144.62-84.26-65.80-45.32-5.59
Reserve excluding Revaluation Reserve15735.4424935.5013088.5416511.9919704.23
Revaluation reserve0.000.000.000.000.00
Shareholder's Funds17412.7326629.5614782.6018206.0521398.29
Minority Interest0.000.000.000.000.00
Long-Term Borrowings0.000.000.000.000.00
Secured Loans0.000.000.000.000.00
    Non Convertible Debentures0.000.000.000.000.00
    Converible Debentures & Bonds0.000.000.000.000.00
    Packing Credit - Bank0.000.000.000.000.00
    Inter Corporate & Security Deposit0.000.000.000.000.00
    Term Loans - Banks0.000.000.000.000.00
    Term Loans - Institutions0.000.000.000.000.00
    Other Secured0.000.000.000.000.00
Unsecured Loans0.000.000.000.241.77
    Fixed Deposits - Public0.000.000.000.000.00
    Loans and advances from subsidiaries0.000.000.000.000.00
    Inter Corporate Deposits (Unsecured)0.000.000.000.000.00
    Foreign Currency Convertible Notes0.000.000.000.000.00
    Long Term Loan in Foreign Currency0.000.000.000.000.00
    Loans - Banks0.000.000.000.000.00
    Loans - Govt.0.000.000.000.000.00
    Loans - Others0.000.000.000.000.00
    Other Unsecured Loan0.000.000.000.241.77
Deferred Tax Assets / Liabilities-1335.46-1131.48-1031.26-1104.86-622.22
    Deferred Tax Assets1517.421320.341186.971277.24863.39
    Deferred Tax Liability181.96188.86155.71172.38241.18
Other Long Term Liabilities41.3996.82223.08289.1022.08
Long Term Trade Payables0.000.000.000.000.00
Long Term Provisions2548.032622.122594.992617.4529202.05
Total Non-Current Liabilities1253.961587.451786.811801.9328603.69
Current Liabilities
Trade Payables4277.895793.274661.303570.604058.15
    Sundry Creditors4277.895793.274661.303570.604058.15
    Acceptances0.000.000.000.000.00
    Due to Subsidiaries- Trade Payables0.000.000.000.000.00
Other Current Liabilities1845.875037.374501.062228.488027.11
    Bank Overdraft / Short term credit0.000.000.000.000.00
    Advances received from customers70.7843.4749.1037.9644.27
    Interest Accrued But Not Due0.000.000.000.000.00
    Share Application Money0.000.000.000.000.00
    Current maturity of Debentures & Bonds0.000.000.000.000.00
    Current maturity - Others0.000.000.001.530.00
    Other Liabilities1775.094993.904451.962188.997982.84
Short Term Borrowings0.000.000.000.000.00
    Secured ST Loans repayable on Demands0.000.000.000.000.00
    Working Capital Loans- Sec0.000.000.000.000.00
    Buyers Credits - Unsec0.000.000.000.000.00
    Commercial Borrowings- Unsec0.000.000.000.000.00
    Other Unsecured Loans0.000.000.000.000.00
Short Term Provisions7139.956153.654383.454420.4215955.40
    Proposed Equity Dividend0.000.000.000.000.00
    Provision for Corporate Dividend Tax0.000.000.000.000.00
    Provision for Tax2962.042962.041637.231613.7615031.79
    Provision for post retirement benefits44.8434.2033.6032.6121.47
    Preference Dividend0.000.000.000.000.00
    Other Provisions4133.073157.422712.632774.05902.14
Total Current Liabilities13263.7016984.2913545.8110219.5028040.66
Total Liabilities31930.3945201.3030115.2130227.4878042.64
ASSETS
Gross Block6497.915916.466006.5014523.515590.54
Less: Accumulated Depreciation3208.932622.042150.906957.611290.62
Less: Impairment of Assets0.000.000.000.000.00
Net Block3288.983294.433855.607565.904299.93
Lease Adjustment A/c0.000.000.000.000.00
Capital Work in Progress203.12305.02132.141201.2210026.44
Non Current Investments0.000.000.000.000.57
Long Term Investment0.000.000.000.000.57
    Quoted0.000.000.000.000.00
    Unquoted0.000.000.000.000.57
Long Term Loans & Advances3426.394454.934017.083624.9330028.83
Other Non Current Assets58.6454.5470.4971.6878.42
Total Non-Current Assets6987.748120.978088.8212478.6644450.55
Current Assets Loans & Advances
Currents Investments5182.893655.920.000.000.00
    Quoted5182.893655.920.000.000.00
    Unquoted0.000.000.000.000.00
Inventories4599.705346.955466.984830.324864.94
    Raw Materials1044.801071.09912.81764.791155.39
    Work-in Progress9.528.7613.01307.26220.90
    Finished Goods1008.301505.561278.78923.831740.68
    Packing Materials0.000.000.000.000.00
    Stores  and Spare38.5038.8237.9134.2032.54
    Other Inventory2498.582722.743224.462800.251715.43
Sundry Debtors1923.752052.392156.05998.011204.87
    Debtors more than Six months167.46256.58249.050.000.00
    Debtors Others1884.971998.142107.701178.111357.57
Cash and Bank11559.2824845.0811579.6410832.0311713.46
    Cash in hand0.000.000.000.000.00
    Balances at Bank11559.2824845.0811579.6410197.8411640.81
    Other cash and bank balances0.000.000.00634.1972.65
Other Current Assets1554.84894.90457.71484.671089.75
    Interest accrued on Investments140.7676.3775.08232.22224.94
    Interest accrued on Debentures0.000.000.000.000.00
    Deposits with Government0.000.000.000.000.00
    Interest accrued and or due on loans0.000.000.000.000.00
    Prepaid Expenses149.60139.26146.49117.89111.30
    Other current_assets1264.48679.27236.14134.56753.51
Short Term Loans and Advances122.18283.96564.83602.6614685.80
    Advances recoverable in cash or in kind78.43186.71101.38170.30302.22
    Advance income tax and TDS0.000.000.000.0013497.47
    Amounts due from directors0.000.000.000.000.00
    Due From Subsidiaries0.000.000.000.000.00
    Inter corporate deposits0.000.000.000.000.00
    Corporate Deposits0.000.000.000.000.00
    Other Loans & Advances43.7597.25463.45432.36886.11
Total Current Assets24942.6537079.2020225.2117747.6933558.81
Net Current Assets (Including Current Investments)11678.9420094.916679.417528.195518.15
Miscellaneous Expenses not written off0.000.000.000.000.00
Total Assets31930.3945201.3030115.2130227.4878042.64
Contingent Liabilities3538.693547.774910.464766.855340.12
Total Debt0.000.000.241.775.83
Book Value102.89157.1987.26107.47126.31
Adjusted Book Value102.89157.1987.26107.47126.31

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.